DK1280404T3 - Model for neurodegenerativ sygdom - Google Patents

Model for neurodegenerativ sygdom

Info

Publication number
DK1280404T3
DK1280404T3 DK01936609T DK01936609T DK1280404T3 DK 1280404 T3 DK1280404 T3 DK 1280404T3 DK 01936609 T DK01936609 T DK 01936609T DK 01936609 T DK01936609 T DK 01936609T DK 1280404 T3 DK1280404 T3 DK 1280404T3
Authority
DK
Denmark
Prior art keywords
model
neurodegenerative disease
3beta
gsk
protein
Prior art date
Application number
DK01936609T
Other languages
Danish (da)
English (en)
Inventor
Grado Jesus Avila De
Jose Javier Lucas Lozano
Felix Hernandez Perez
Original Assignee
Consejo Superior Investigacion
Univ Madrid Autonoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior Investigacion, Univ Madrid Autonoma filed Critical Consejo Superior Investigacion
Application granted granted Critical
Publication of DK1280404T3 publication Critical patent/DK1280404T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0312—Animal model for Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0318—Animal model for neurodegenerative disease, e.g. non- Alzheimer's

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Catching Or Destruction (AREA)
  • Housing For Livestock And Birds (AREA)
  • Endoscopes (AREA)
  • Toys (AREA)
DK01936609T 2000-05-18 2001-05-18 Model for neurodegenerativ sygdom DK1280404T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0012056.8A GB0012056D0 (en) 2000-05-18 2000-05-18 Model for neurodegenerative disease

Publications (1)

Publication Number Publication Date
DK1280404T3 true DK1280404T3 (da) 2006-10-30

Family

ID=9891881

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01936609T DK1280404T3 (da) 2000-05-18 2001-05-18 Model for neurodegenerativ sygdom

Country Status (17)

Country Link
US (1) US7265259B2 (de)
EP (1) EP1280404B1 (de)
JP (2) JP2003533227A (de)
KR (1) KR100764889B1 (de)
CN (1) CN100352927C (de)
AT (1) ATE332078T1 (de)
AU (2) AU2001262482B2 (de)
CA (1) CA2409075A1 (de)
CY (1) CY1105641T1 (de)
DE (1) DE60121324T2 (de)
DK (1) DK1280404T3 (de)
ES (1) ES2267773T3 (de)
GB (1) GB0012056D0 (de)
IL (2) IL152844A0 (de)
MX (1) MXPA02011391A (de)
PT (1) PT1280404E (de)
WO (1) WO2001088109A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2408747C (en) 2000-05-11 2011-04-05 Consejo Superior Investigaciones Cientificas Heterocyclic inhibitors of glycogen synthase kinase gsk-3
KR101040757B1 (ko) * 2008-04-11 2011-06-10 임재주 안전모
US11168369B2 (en) 2014-11-25 2021-11-09 The Brigham And Women's Hospital, Inc. Method of identifying and treating a person having a predisposition to or afflicted with a cardiometabolic disease
US10683552B2 (en) 2014-11-25 2020-06-16 Presidents And Fellows Of Harvard College Clonal haematopoiesis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2923279C2 (de) * 1979-06-08 1987-07-09 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von Pankreatin-Pellets und diese enthaltende Arzneimittel
GB9316727D0 (en) * 1993-08-12 1993-09-29 Inst Of Psychiatry Models of alzheimers's disease
EP0920495B1 (de) * 1996-07-24 2008-05-07 Novartis AG Transgentier-modell für die krankheit von alzheimer
EP1216297A2 (de) * 1999-07-02 2002-06-26 Janssen Pharmaceutica N.V. Doppeltransgene tiermodelle für neurodegenerative krankheite

Also Published As

Publication number Publication date
CN1443038A (zh) 2003-09-17
JP2003533227A (ja) 2003-11-11
WO2001088109A3 (en) 2002-07-04
CN100352927C (zh) 2007-12-05
IL152844A0 (en) 2003-06-24
GB0012056D0 (en) 2000-07-12
AU2001262482B2 (en) 2006-06-08
ES2267773T3 (es) 2007-03-16
PT1280404E (pt) 2006-11-30
US20030177510A1 (en) 2003-09-18
DE60121324T2 (de) 2007-07-05
CA2409075A1 (en) 2001-11-22
KR20030027892A (ko) 2003-04-07
WO2001088109A2 (en) 2001-11-22
KR100764889B1 (ko) 2007-10-09
CY1105641T1 (el) 2010-12-22
DE60121324D1 (de) 2006-08-17
EP1280404B1 (de) 2006-07-05
ATE332078T1 (de) 2006-07-15
JP2012085653A (ja) 2012-05-10
US7265259B2 (en) 2007-09-04
MXPA02011391A (es) 2004-08-12
IL152844A (en) 2008-11-26
EP1280404A2 (de) 2003-02-05
AU6248201A (en) 2001-11-26
WO2001088109A8 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
EP1311530A4 (de) Herstellung von humanisierten antikörpern in transgenen tieren
ATE401787T1 (de) Menschliches cd20 exprimierende transgene mäuse
EP1463522A4 (de) Humane antipneumokokken-antikörper von nichthumanen tieren
EP1391511A4 (de) Künstliches menschliches chromosom mit dem gen für die lambda-leichte kette menschlicher antikörper
BR0314814A (pt) Variantes otimizadas de fc e métodos para sua geração
EA200601603A1 (ru) Миметические антитела glp-1 человека, композиции, способы и применения
CY2013025I2 (el) Ετερολογος εκφραση των πρωτεϊνων της neisseria
EA200600525A1 (ru) Еро-имитирующие миметичекие антитела человека с центральной шарнирной областью, композиции, способы и применения
DK1354034T3 (da) Transgene transchromosomale gnavere til fremstilling af humane antistoffer
DE60143301D1 (de) Polyarylcarboxamide zur verwendung als lipidsenker
BR0113110A (pt) Anticorpos anti-tnf, composições, métodos e usos
TR200300478T2 (tr) Hümanize antiLT-ß-R antikorları
EP1506286A4 (de) Neutralisierung eines menschlichen anti-igfr-antikörpers
PT1644484E (pt) Células autólogas de indução de auto-tolerância de origem monocítica e sua utilização em preparações farmacêuticas
EP1452093A4 (de) Chimäres nichtmenschliches tier
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
EP1251863A4 (de) 22 sezernierte humane proteine
CY1108221T1 (el) Μεθοδος για την αναπαραγωγη πλευρομουτιλινων
ATE541923T1 (de) Transgener c. elegans als modellorganismus für untersuchungen zur alzheimer'schen krankheit
ATE332078T1 (de) Tiermodel für neurodegenerative erkrankungen
PT1267915E (pt) Metodos para tratar doencas com proteina c activada
EE05634B1 (et) Geneetiline test kompleksset selgroo v„„rarengut kandvate veiste tuvastamiseks
EP1556499A4 (de) Für kariogene bakterien spezifische monoklonale antikörper
NO20006035L (no) Dyrkingsanlegg for akvatiske organismer
ATE499832T1 (de) Transgenes tiermodel für neurodegenerative krankheiten